Commentary: chemotherapy dosing in obese patients with cancer-the need for evidence-based clinical practice guidelines.
Publication
, Journal Article
Lyman, GH
Published in: J Oncol Pract
January 2011
Duke Scholars
Published In
J Oncol Pract
DOI
EISSN
1935-469X
Publication Date
January 2011
Volume
7
Issue
1
Start / End Page
17 / 18
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Lyman, G. H. (2011). Commentary: chemotherapy dosing in obese patients with cancer-the need for evidence-based clinical practice guidelines. J Oncol Pract, 7(1), 17–18. https://doi.org/10.1200/JOP.2010.000200
Lyman, Gary H. “Commentary: chemotherapy dosing in obese patients with cancer-the need for evidence-based clinical practice guidelines.” J Oncol Pract 7, no. 1 (January 2011): 17–18. https://doi.org/10.1200/JOP.2010.000200.
Lyman GH. Commentary: chemotherapy dosing in obese patients with cancer-the need for evidence-based clinical practice guidelines. J Oncol Pract. 2011 Jan;7(1):17–8.
Lyman, Gary H. “Commentary: chemotherapy dosing in obese patients with cancer-the need for evidence-based clinical practice guidelines.” J Oncol Pract, vol. 7, no. 1, Jan. 2011, pp. 17–18. Pubmed, doi:10.1200/JOP.2010.000200.
Lyman GH. Commentary: chemotherapy dosing in obese patients with cancer-the need for evidence-based clinical practice guidelines. J Oncol Pract. 2011 Jan;7(1):17–18.
Published In
J Oncol Pract
DOI
EISSN
1935-469X
Publication Date
January 2011
Volume
7
Issue
1
Start / End Page
17 / 18
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- 1112 Oncology and Carcinogenesis